James Murray is a seasoned professional in the field of chemistry with extensive experience in process development and synthetic chemistry. At Amgen since February 2019, James serves as the Kinetic Analysis Platform Lead, focusing on pivotal drug substance technologies and predictive modeling for process optimization. Prior experience includes a research associate role at The Scripps Research Institute, where James conducted Origins of Life studies, and a Ph.D. in Organic Chemistry from Imperial College London. Earlier positions also encompass internships and placements at Roche and GlaxoSmithKline, emphasizing medicinal chemistry and site-specific drug delivery systems. Educational qualifications include a First Class Bachelor's degree in Medicinal and Pharmaceutical Chemistry from Trinity College Dublin and foundational studies at the University of Strathclyde and Glasgow High School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices